Literature DB >> 21705877

Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.

Kyung-Chul Yoon1, Seong-Kyu Im, Hwang-Gyun Kim, In-Cheon You.   

Abstract

PURPOSE: To determine the relative staining characteristics of the nasal and temporal conjunctiva as compared with other measures of dry eye and evaluate the qualitative clinical impression of the utility of the double vital staining with fluorescein and lissamine green.
METHODS: Ocular surface staining was performed with a mixture of 1% fluorescein and 1% lissamine green in 50 patients with dry eye (12 patients with Sjögren syndrome and 38 patients with non-Sjögren syndrome). Ocular surface disease index (OSDI), tear breakup time (BUT), and Schirmer test were evaluated. Digital photographs were taken after vital staining on the ocular surface, and the grade of staining in various areas was assessed. Correlation among the degrees of staining, OSDI, and ocular surface parameters was analyzed.
RESULTS: The nasal conjunctiva evidenced greater staining compared with the temporal conjunctiva and cornea (P = 0.04). Staining of the nasal conjunctiva showed significant correlation with OSDI (P < 0.01) and BUT (P = 0.03). Staining of the temporal conjunctiva correlated significantly with OSDI (P = 0.01), and staining of the cornea correlated with BUT (P = 0.02).
CONCLUSIONS: Double vital staining with 1% fluorescein and 1% lissamine green correlates with symptoms and some ocular surface parameters in patients with dry eye and helps to identify ocular surface changes easily. It may be a useful method for the diagnosis of dry eye and the assessment of the therapeutic effect in patients with dry eye syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705877     DOI: 10.1097/ICO.0b013e31820687dd

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  16 in total

1.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

2.  Higher order aberrations of the corneal surface after laser subepithelial keratomileusis.

Authors:  Hyun Ho Jung; Yong Sok Ji; Han Jin Oh; Kyung Chul Yoon
Journal:  Korean J Ophthalmol       Date:  2014-07-22

3.  Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.

Authors:  Lian Cui; Ying Li; Hyo Seok Lee; Jee Myung Yang; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-08-18       Impact factor: 2.031

4.  Discordant Dry Eye Disease (An American Ophthalmological Society Thesis).

Authors:  Roni M Shtein; Daniel E Harper; Vincent Pallazola; Steven E Harte; Munira Hussain; Alan Sugar; David A Williams; Daniel J Clauw
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

5.  Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.

Authors:  Yeon Soo Kang; Hyo Seok Lee; Ying Li; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-05-31       Impact factor: 2.031

6.  Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.

Authors:  Koray Gumus; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2021-02-08       Impact factor: 5.488

Review 7.  Associations between signs and symptoms of dry eye disease: a systematic review.

Authors:  Jimmy D Bartlett; Michael S Keith; Lavanya Sudharshan; Sonya J Snedecor
Journal:  Clin Ophthalmol       Date:  2015-09-16

Review 8.  Diagnosis of dry eye disease and emerging technologies.

Authors:  Maya Salomon-Ben Zeev; Darby Douglas Miller; Robert Latkany
Journal:  Clin Ophthalmol       Date:  2014-03-20

9.  Comparison of the Safety and Efficacy between Preserved and Preservative-Free Latanoprost and Preservative-Free Tafluprost.

Authors:  Joon Mo Kim; Sang Woo Park; Mincheol Seong; Seung Joo Ha; Ji Woong Lee; Seungsoo Rho; Chong Eun Lee; Kyoung Nam Kim; Tae-Woo Kim; Kyung Rim Sung; Chan Yun Kim
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

10.  Clinical Effect of Antioxidant Glasses Containing Extracts of Medicinal Plants in Patients with Dry Eye Disease: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Won Choi; Jae Chan Kim; Won Soo Kim; Han Jin Oh; Jee Myung Yang; Jee Bum Lee; Kyung Chul Yoon
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.